drugset
drugset / Trial / NCT00816348

Compassionate Use of Omegaven IV Fat Emulsion

NCT00816348 ↗

Phase 2 Terminated 15 enrolled Cindy Haller
NaSingle-groupOpen-labelTreatment

Summary

This is a compassionate use protocol to use intravenous fish oil infusion, Omegaven®, to infants and children with parenteral nutrition-associated liver disease to enable reversal of elevated serum liver enzymes and direct bilirubin (cholestasis).

Timeline

Start
2008-12
Primary completion
2014-02
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Omegaven Other / unclassified 1 g/kg Intravenous

Indications

parenteral nutrition-associated cholestasis